US2015197751A1PendingUtilityA1
Rnai expression constructs
Est. expiryFeb 3, 2025(expired)· nominal 20-yr term from priority
C12N 2310/531C12N 15/111C12N 2770/24211C12N 2310/14C12N 2310/111C12N 2310/53C12N 2310/51C12N 2330/30C12N 15/1131C12N 15/113
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A genetic construct capable of modifying expression of one or more genes, the genetic construct comprising an RNAi expression cassette comprising a promoter and two or more stem-loop structures separated by one or more spacer regions, the stem-loop structures being RNAi agents when transcribed from the promoter.
2 . The genetic construct of claim 1 wherein the stem-loop structures target one or more sequences as set forth in any of SEQ ID No: 1-56.
3 . A 1-x RNA expression cassette comprising a promoter and two or more stem-loop structures separated from one another by one or more spacer regions, the cassette encoding two or more RNAi agents for modifying target gene expression.
4 . The cassette of claim 3 wherein the stem-loop structures target one or more sequences as set forth in any of SEQ ID No: 1-56.
5 . A method of modifying the expression of one or more genes, comprising:
introducing to a cell, tissue, or organ of interest a genetic construct comprising an RNAi expression cassette comprising a promoter and two or more stem-loop structures separated from one another by one or more spacer regions, the stem-loop structures being RNAi agents when transcribed from the promoter.
6 . The method of claim 13 wherein the stem-loop structures target one or more sequences as set forth in any of SEQ ID NO: 1-56.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.